Castle Biosciences' Receivables - Net fell 154.99% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.5 million, marking a year-over-year decrease of 154.99%. This contributed to the annual value of $51.2 million for FY2024, which is 3372.15% up from last year.
Castle Biosciences' Receivables - Net amounted to $49.5 million in Q3 2025, which was down 154.99% from $52.3 million recorded in Q2 2025.
In the past 5 years, Castle Biosciences' Receivables - Net ranged from a high of $56.4 million in Q1 2025 and a low of $14.3 million during Q1 2021
In the last 5 years, Castle Biosciences' Receivables - Net had a median value of $31.3 million in 2023 and averaged $33.7 million.
In the last 5 years, Castle Biosciences' Receivables - Net plummeted by 210.96% in 2021 and then soared by 6315.39% in 2023.
Castle Biosciences' Receivables - Net (Quarter) stood at $17.3 million in 2021, then skyrocketed by 35.84% to $23.5 million in 2022, then skyrocketed by 63.15% to $38.3 million in 2023, then surged by 33.72% to $51.2 million in 2024, then fell by 3.39% to $49.5 million in 2025.
Its Receivables - Net was $49.5 million in Q3 2025, compared to $52.3 million in Q2 2025 and $56.4 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value